Inflammatory Breast Cancer Clinical Trials
The Morgan Welch Inflammatory Breast Cancer (IBC) Research Program is conducting treatment-based studies and a wide variety of lab-based studies to understand this disease better. Additional IBC clinical trials can be found at ClinicalTrials.gov.
If you would like more information about becoming involved with our clinical trials in general, you may email our program at IBCP@MDAnderson.org.
IBC Registry
Protocol 2006-1072: Inflammatory breast cancer registry (Also open at select IBC Connect sites around the United States)
Contact Info:
Study Manager: Angela Alexander, Ph.D., AAlexand@MDAnderson.org
Principal Investigator: Vicente Valero, M.D., VValero@MDAnderson.org
The IBC Registry is our master biospecimen banking study, that allows us to collect data, blood and tissue samples to support the entire research program at UT MD Anderson and beyond. All patients with diagnosed or suspected IBC are eligible to be enrolled, regardless of treatment choices.
Ongoing Trials for Newly Diagnosed IBC
Protocol 2023-0100: TRUDI: A Phase 2 study of neoadjuvant trastuzumab deruxtecan and durvalumab for stage III, HER2-expressing inflammatory breast cancer
Contact Info:
Study Manager: Angela Marx, R.N., ANMarx@MDAnderson.org
Principal Investigator: Rachel Layman, M.D., RLayman@MDAnderson.org
Protocol 2024-0142: S2206, Phase 3 trial of neoadjuvant durvalumab (NSC 778709) plus chemotherapy versus chemotherapy alone for adults with MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) positive/Human Epidermal Growth Factor Receptor (HER2) negative stage 2-3 breast cancer
Contact Info:
Principal Investigator: Rachel Layman, M.D., RLayman@MDAnderson.org
Ongoing Trials for Adjuvant Treatment
No adjuvant trials are currently enrolling.
Ongoing Local Therapy Trials
Protocol SWOG 1706: A Phase 2 randomized study of olaparib (NSC-747856) administered concurrently with radiotherapy versus radiotherapy alone for inflammatory breast cancer
Contact Info:
Principal Investigator: Wendy Woodward, M.D., Ph.D., WWoodward@MDAnderson.org
Ongoing Trials for Metastatic/Recurrent IBC
No metastatic/recurrent trials are currently enrolling.
Give Now
Research Areas
Find out about the four types of research taking place at UT MD Anderson.